Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI
1 other identifier
interventional
16
1 country
1
Brief Summary
The purpose of this study is to determine if certain MRI sequences can accurately diagnose adrenal masses of unknown origin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2003
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2003
CompletedFirst Submitted
Initial submission to the registry
July 23, 2008
CompletedFirst Posted
Study publicly available on registry
July 25, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedDecember 6, 2012
December 1, 2012
6.8 years
July 23, 2008
December 4, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnosis of either benign or malignant adrenal mass on pathology
definitive diagnosis of adrenal mass
0-6 months
Secondary Outcomes (1)
stability of growth of mass on follow up imaging
3-24 months
Study Arms (1)
adrenal mass group
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Patients can participate in this study if they are 18 years of age or older and if they have had a Cat Scan (CT scan) performed with and without contrast media (medication given intravenously to enhance the CT images) or if patients are scheduled to have a CT scan performed and if the reason their physician ordered the CT is because they have an adrenal mass of an unknown type.
You may not qualify if:
- Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
- Pregnant patients or patients who are lactating.
- A patient who is claustrophobic and would require sedation to complete the MRI exam.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 23, 2008
First Posted
July 25, 2008
Study Start
October 1, 2003
Primary Completion
July 1, 2010
Study Completion
July 1, 2012
Last Updated
December 6, 2012
Record last verified: 2012-12